ArticleEpilepsia2025

Real-world retention of newer ASMs, including lacosamide and brivaracetam as first or second therapies in adult-onset epilepsy.

André Idegård et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.